Good morning everyone, it’s been a while since I have posted anything. I was watching the video last night of Tomc from TDameritrade. He mentions the PTSD study that CVSI provides all of the products for had a positive result. He was careful not to give to much info and deflected saying the outcomes are complicated however the only current treatment is opioids.
Here is where I’m going with this, in clinical trials since we are the company that supplied the CBD product, should they go the FDA route and file an NDA, it would be based off our our product alone as this is the one that has shown the results in a clinical setting. Given the dangers of opioids this could be an enormous opportunity for the pharma side of CVSI. I’m thinking if they go this route they would probably get sub part H approval, early approval with additional studies needed, since there is no good alternative available.
Anyone have any thoughts or could ask this question on the investors call?
Market Data 
Markets 
AI
